Updated Jul 16, 2026
Ring Christine has filed 6 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.59M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale | 11.0K | $23.56 | $259K |
| 2026-07-02 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 5.8K | $8.72 | $50K |
| 2026-07-02 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 5.2K | $1.86 | $10K |
| 2026-06-25 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale | 28.9K | $20.06 | $581K |
| 2026-06-25 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 15.6K | $8.72 | $136K |
| 2026-06-25 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 13.3K | $7.26 | $97K |
| 2026-06-02 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale | 8.1K | $16.60 | $135K |
| 2026-06-02 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 3.4K | $1.86 | $6K |
| 2026-05-04 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale | 8.1K | $16.96 | $138K |
| 2026-05-01 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale | 5.4K | $16.76 | $90K |
| 2026-04-30 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale | 3.2K | $16.65 | $53K |
| 2026-04-30 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 2.9K | $0.00 | |
| 2026-04-30 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 3.8K | $0.00 | |
| 2026-04-30 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 2.0K | $0.00 | |
| 2026-04-02 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale [10b5-1] | 8.1K | $15.24 | $124K |
| 2026-03-03 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale [10b5-1] | 8.1K | $15.44 | $126K |
| 2026-02-10 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale [10b5-1] | 14.3K | $16.66 | $238K |
| 2026-01-31 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale | 88 | $17.37 | $2K |
| 2026-01-31 | NRIX | Nurix Therapeutics, Inc. | S — Open-market sale | 4.3K | $16.58 | $72K |
| 2026-01-31 | NRIX | Nurix Therapeutics, Inc. | M — Option exercise | 2.9K | $0.00 |
Ring Christine is a corporate insider — currently tracked as Chief Legal Officer of Nurix Therapeutics, Inc. (NRIX). InsiderAlpha tracks every SEC Form 4 filing in real time.
6 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 20 open-market sales ($2.59M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ring Christine profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.